Anticancer Agents Med Chem. 2009 Jan;9(1):51-4.

Targeting the SUMO E2 conjugating enzyme Ubc9 interaction for anti-cancer drug design.

Source

James Graham Brown Cancer Center, University of Louisville, 529 South Jackson Street, Louisville, Kentucky, 40202, USA.

Abstract

Sumoylation has been implicated in a variety of cancers, suggesting that sumoylation manipulation could be one approach for regulating tumorgenesis. Ubc9 exerts a central function for the sumoylation pathway, interacting with almost all the partners required for sumoylation. The high-resolution structure available for Ubc9 as well as the recent determination of more interacting partner complex structures makes rational drug design that target Ubc9 possible. Structure-based virtual drug screening has been used increasingly as the first step of drug design to select potential lead templates. This review analyzes all the interfaces between Ubc9 and its binding partners while also highlighting the possible targeting sites on Ubc9 best suited for virtual screening and drug design.

PMID:: 19149481; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Review Targeting Ubc9 for cancer therapy. [Expert Opin Ther Targets. 2005]
Review Targeting Ubc9 for cancer therapy.
Mo YY, Moschos SJ. Expert Opin Ther Targets. 2005 Dec; 9(6):1203-16.
Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR data. [Proteins. 2005]
Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR data.
Ding H, Yang Y, Zhang J, Wu J, Liu H, Shi Y. Proteins. 2005 Dec 1; 61(4):1050-8.
Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. [J Virol. 2006]
Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation.
Tomoiu A, Gravel A, Tanguay RM, Flamand L. J Virol. 2006 Oct; 80(20):10218-28.
A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells. [Int J Oncol. 2009]
A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
Xu J, Watkins T, Reddy A, Reddy ES, Rao VN. Int J Oncol. 2009 Apr; 34(4):939-49.
Review Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS). [Methods Mol Biol. 2009]
Review Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
Niedenthal R. Methods Mol Biol. 2009; 497:63-79.

See reviews... See all...

Cited by 1 PubMed Central article

An acidic loop and cognate phosphorylation sites define a molecular switch that modulates ubiquitin charging activity in Cdc34-like enzymes. [PLoS Comput Biol. 2011]
An acidic loop and cognate phosphorylation sites define a molecular switch that modulates ubiquitin charging activity in Cdc34-like enzymes.
Papaleo E, Ranzani V, Tripodi F, Vitriolo A, Cirulli C, Fantucci P, Alberghina L, Vanoni M, De Gioia L, Coccetti P. PLoS Comput Biol. 2011 May; 7(5):e1002056. Epub 2011 May 26.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Targeting the SUMO E2 conjugating enzyme Ubc9 interaction for anti-cancer drug d...
Targeting the SUMO E2 conjugating enzyme Ubc9 interaction for anti-cancer drug design.
Anticancer Agents Med Chem. 2009 Jan ;9(1):51-4.

PubMed
Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independen...
Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
Biochemistry. 2000 Mar 28 ;39(12):3433-40.

PubMed
X-Y translocations and sex differentiation.
X-Y translocations and sex differentiation.
Semin Reprod Med. 2001 Jun ;19(2):133-9.

PubMed
Recording high quality speech during tagged cine-MRI studies using a fiber optic...
Recording high quality speech during tagged cine-MRI studies using a fiber optic microphone.
J Magn Reson Imaging. 2006 Jan ;23(1):92-7.

PubMed
Hippocampal correlates of pain in healthy elderly adults: a pilot study.
Hippocampal correlates of pain in healthy elderly adults: a pilot study.
Neurology. 2009 Nov 10 ;73(19):1567-70.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: